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Abstract 
Introduction: Well-differentiated papillary thyroid carcinoma generally (PTC) have a favorable prognosis. This metas-
tasis is rare in the central nervous system. Brain metastasis has a relatively poor prognosis. We present a rare case of 
cerebellar metastasis, one that mimics a solid type cerebellar hemangioblastoma and because of which it was very 
hard to reach accurate preoperative diagnosis. Accurate diagnosis was challenging because of the similar imaging 
and histopathological findings for these two tumors.
Case description: A brain lesion was detected by routine medical checkup of the brain with MRI in a 49-year-old 
woman 2 years after thyroidectomy for well-differentiated PTC. Gadolinium-enhanced MRI showed a homogeneous 
prominently enhanced lesion with surrounding enhanced dilated vessels in the left cerebellar hemisphere. Digital 
subtraction angiography showed a strongly stained lesion fed by the peripheral branch of the left posterior inferior 
cerebellar artery with drainage into the inferior vermian vein, revealing arteriovenous shunting. The most like likely 
preoperative diagnosis was felt to be that of a solid cerebellar hemangioblastoma. Gross total resection of the tumor 
was achieved by bilateral suboccipital craniotomy, and intraoperative pathological analysis suggested hemangioblas-
toma. Histopathological findings showed proliferation of vacuolated sheeted tumor cells with clear and eosinophilic 
cytoplasm and numerous thin-walled microvessels, consistent with hemangioblastoma. However, the final diagnosis 
was brain metastasis of the follicular variant of PTC due to a partial thyroid follicle-like pattern including eosinophilic 
fluid pathologically and positive TTF-1 immunostaining.
Discussion and evaluation: Since presented rare case of cerebellar metastasis of PTC was very similar to solid 
type cerebellar hemangioblastoma on imaging and histopathological findings, accurate diagnosis was challenging. 
Moreover, it is extremely rare for a cerebellar metastasis to occur as an initial distant metastasis of PTC, and hemangio-
blastoma is the most common primary cerebellar neoplasm in adults. This epidemiological data was also one of the 
reason of difficulty to reach preoperative accurate diagnosis.
Conclusions: To the best of our knowledge, there are no other reports of challenging diagnosis case of these two 
tumors in the literature. Brain metastasis of a well-differentiated PTC could be a relatively poor prognostic factor, and 
accurate diagnosis and suitable surgical therapy or radiotherapy are needed.
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Background
Papillary thyroid carcinoma (PTC) is the most common 
thyroid carcinoma, representing approximately 80  % of 
newly diagnosed thyroid carcinomas (Hjiyiannakis et al. 
1996). PTCs are characterized by a slowly progressive 
course and a 10-year survival rate of 80–95 % (Schlum-
berger 1998). Distant metastases are seen in a minority 
of patients, at rates of 4–15  % (Hoie et  al. 1988; Casara 
et al. 1993; Shaha et al. 1997; Clark et al. 2005; Aggarwal 
et al. 2007), and are most common in the lungs, followed 
by bone (Mazzaferri and Massoll 2002). Brain metasta-
ses are rare, occurring in roughly 0.15–1.3  % of thyroid 
carcinomas (Parker et al. 1986). Here, we present a case 
with brain metastasis of PTC that mimicked cerebellar 
hemangioblastoma radiographically and pathologically. 
This case illustrates the challenge of differential diagnosis 
of cerebellar hemangioblastoma and a metastatic cerebel-
lar tumor of PTC.
Case description
A 49-year-old woman visited our institute for an inci-
dentally detected brain tumor during the routine medi-
cal checkup of the brain with MRI. She had a history of 
hysterectomy for uterine myoma 6  years ago and total 
thyroidectomy for thyroid carcinoma that was diagnosed 
as well-differentiated PTC 2  years ago. TNM-stage was 
Stage III (T3N0M0) when thyroidectomy. Radioiodine 
treatment was not performed because of no evidence 
of invasion to surrounding tissue, lymph node metasta-
sis and distal metastasis. She also had a familial history 
of thyroid carcinoma, since her mother had suffered 
from the same thyroid tumor. Physical and neurological 
examinations were all normal with no deficit. All serum 
tumor markers were within the normal range. Computed 
tomography showed that the tumor was a homogene-
ously enhanced mass lesion in the left cerebellum. Gad-
olinium-enhanced magnetic resonance imaging (MRI) 
showed a homogeneous strongly enhanced hypervascu-
lar lesion with surrounding enhanced vessels located in 
the left cerebellar hemisphere (Fig. 1a, b). Digital subtrac-
tion angiography showed a strongly stained lesion fed by 
the peripheral branch (tonsillohemispheric segment) of 
the left posterior inferior cerebellar artery (PICA) and 
draining into the inferior vermian vein, revealing arterio-
venous shunting (Fig.  1c–f). Preoperative thyroglobulin 
(Tg) was 9.5  ng/ml (normal range: 0–50), and anti-thy-
roglobulin antibody (Anti-Tg antibody) measured by 
FEIA method was under 6.0 IU/ml (normal range: under 
13.6). A pre-diagnosis of solid type cerebellar hemangio-
blastoma was made based on these radiographic findings 
and the epidemiology that it is the most common pri-
mary cerebellar neoplasm in adults (Committee of Brain 
Tumor Registry of Japan 2014).
We performed tumor resection by bilateral suboc-
cipital approach. By opening the arachnoid membrane 
between the vermis and left biventral lobule, a long 
perspective from the proximal to distal portion of the 
PICA across the predicted location of the tumor bulk 
was exposed. The tumor position was identified using a 
navigation system, and the exposed well-margined tumor 
bulk was totally resected after dissecting the feeding 
artery from the PICA peripheral branch and the draining 
vein into the left inferior vermian vein. An intraoperative 
pathological examination was performed, and the frozen 
section of the tumor tissue showed that polygonal cells 
proliferated in nests and cords with many blood vessels 
(Fig. 2a). The findings appeared compatible with heman-
gioblastoma. Postoperatively, the patient had no physical 
or neurological symptoms.
Histological examination of the formalin-fixed paraf-
fin-embedded tumor tissue revealed proliferation of vac-
uolated sheeted tumor cells with clear and eosinophilic 
cytoplasm and numerous thin-walled vessels (Fig.  2b, 
c). A thyroid follicle-like pattern including eosinophilic 
liquid was partially present (Fig.  2d). Irregular nuclear 
contours and nuclear grooves were focally observed. 
Immunohistochemical findings were positive for CD31 
(dilution 1:40; Dako, Japan), CD34 (dilution 1:50; 
Nichirei, Tokyo, Japan), vimentin (dilution 1:50; Dako) 
and thyroid transcription factor-1 (TTF-1) (dilution 
1:200; Dako) (Fig. 2e–h), and negative for GFAP (data not 
shown). The final diagnosis was PTC.
Postoperative MRI showed total resection of the tumor 
bulk and no ischemic complications (Fig.  3). Therefore, 
postoperative radiotherapy and adjuvant therapy were 
not administered. At 2 years postoperatively, the patient 
has no symptoms and no recurrence on follow-up MRI. 
Tg and anti-Tg antibody 2 months and 2 years after oper-
ation were under 0.1 ng/ml and under 6.0 IU/ml, 0.11 ng/
ml and under 6.0 IU/ml, respectively, which all were nor-
mal range.
Discussion and evaluation
Papillary thyroid carcinoma commonly metastasizes to 
regional lymph nodes, lungs, and bones, whereas the 
brain is an uncommon site of metastasis that is found 
in only 0.15–1.3  % of cases (Parker et  al. 1986; Tanaka 
et al. 2013). Moreover, it is extremely rare for a cerebel-
lar metastasis to occur as an initial distant metastasis of 
PTC, with only 16 such cases published to date (Tunio 
et  al. 2015). A brain metastasis of thyroid cancer could 
be a negative prognostic factor and the median sur-
vival in such cases were reported as 4.7 months (includ-
ing anaplastic type 11 cases) (n = 47) (Chiu et al. 1997), 
9.4  months (n  =  9) (Misaki et  al. 2000), 17.4  months 
(n  =  16) (McWilliams et  al. 2003), for a maximum of 
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Fig. 1 Preoperative magnetic resonance imaging and digital subtraction angiography. Preoperative axial (a) and sagittal (b) views in gadolinium-
enhanced T1-weighted MRI, showing a prominent enhanced mass lesion and enhanced vessel-like structures in surrounding parenchyma in the 
left cerebellar hemisphere. Anteroposterior (c) and lateral (d) views in angiography, showing strong tumor staining with a feeding artery from the 
left posterior inferior cerebellar artery, and a draining vein into the left inferior vermian vein, indicating arteriovenous shunt [anteroposterior view (e) 
and lateral view (f)]
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Fig. 2 Photomicrographs showing histological and immunohistochemical findings in tumor tissue. a Intraoperative frozen section of the tumor 
tissue. Polygonal cells proliferated in nests and cords. Many blood vessels (arrows) were found between the nests and cords. Hematoxylin and eosin 
staining in the formalin-fixed paraffin-embedded tumor tissue showed numerous thin-walled microvessels (b) and proliferation of vacuolated 
atypical sheeted tumor cells with clear and eosinophilic cytoplasm (c). d A small part of the tumor had a thyroid follicle-like pattern including 
eosinophilic liquid. CD31 (e) and CD34 (f) staining were positive. g The tumor was diffusely positive for vimentin. h Thyroid transcription factor-1 
(TTF-1)-positive cells were present in part of the tumor. a, b, e–h ×200; c, d ×600
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29.2 months (n = 9) (Kim et al. 2009). Chiu et al. (1997) 
reported that the overall median survival of patients with 
brain metastases from well-differentiated thyroid cancers 
was 12.4 months. Patients with PTC with metastases to 
other organs also have reduced survival after diagnosis of 
a brain metastasis (Biswal et al. 1994; Hjiyiannakis et al. 
1996; Salvati et  al. 2001; McWilliams et  al. 2003; Kim 
et al. 2009; Tsuda et al. 2013).
There are no characteristics of MRI or other radio-
graphic abnormalities that distinguish metastatic lesions 
of thyroid carcinoma from other brain tumors (McWil-
liams et al. 2003; Tunio et al. 2015). There are only three 
cases in which findings in digital subtraction angiography 
have been described (Cha et al. 2000; Hashiba et al. 2006; 
Umehara et  al. 2015). In each of these, relatively promi-
nent-tumor staining with an apparent feeding artery was 
observed, and the consistency of these findings with those 
in our case suggest that a metastatic PTC lesion has a ten-
dency to develop into a vascular-rich tumor bulk. There 
have been five reports of cases exhibiting cerebellar hem-
orrhage secondary to brain metastasis of PTC (Mazzaferri 
et al. 1977; Isoda et al. 1997; Pacak et al. 1998; Lecumberri 
et al. 2010; Tanaka et al. 2013). McWilliams et al. (2003) 
reported that 10 of 16 cases were very or extremely vascu-
lar at the time of surgery or had imaging evidence of hem-
orrhage. This hemorrhagic feature is consistent with the 
angiographic findings, and indicates that brain metastasis 
of PTC is a relatively hypervascular tumor.
Hemangioblastoma typically occurs in the young adult 
and the most common posterior fossa-primary tumors, 
1–2.5 % of all intracranial tumors, approximately 10 % of 
all posterior fossa tumors (Ho et al. 1992; Farrukh 1996) 
and 29  % of all cerebellar tumors (Committee of Brain 
Tumor Registry of Japan 2014). Intracranial heman-
gioblastomas can manifest as four morphologic pat-
terns based on the macroscopic pathology. Type 1 (5  % 
of posterior fossa hemangioblastoma) is a simple cyst 
without a macroscopic nodule. Type 2 is a cyst with a 
mural nodule (60 %). Type 3 is a solid tumors (26 %), and 
type 4 is a solid tumors with small internal cysts (9  %), 
are also seen in the cerebellum (Lee et al. 1989; Ho et al. 
1992; Richard et al. 1998). In gadolinium-enhanced MRI, 
the nodule has prominent enhancement (Ho et al. 1992). 
Since MRI findings for solid hemangioblastomas are sim-
ilar to those in the present case, it was hard to make a 
definite diagnosis based on imaging (Hwang et al. 2015). 
Angiographical findings for hemangioblastoma often 
include enlarged feeding arteries and dilated draining 
veins with dense tumor staining (Ho et al. 1992; Hwang 
et  al. 2015). Angiography in the present case showed a 
hypervascular mass stain with a feeding artery, a drain-
ing vein and an arteriovenous shunt that were also very 
similar to the common findings in hemangioblastoma, 
and distinguishing between these tumors was difficult. 
Pathologically, papillary carcinomas usually share cer-
tain features. The neoplastic papillae contain a central 
core of fibrovascular tissue lined by one or occasionally 
several layers of cells with crowded oval nuclei (LiVolsi 
2011). In the present case, the papillary growth feature 
was not particularly apparent, but vacuolated cells with 
clear to eosinophilic cytoplasm grew as sheet-like struc-
tures accompanied by dense proliferation of small ves-
sels. These features are also similar to the characteristics 
of hemangioblastoma. However, a small fraction of the 
tumor had a thyroid follicular-like pattern with hypereo-
sinophilic colloids, which is characteristic of PTC. Immu-
nohistochemically, papillary carcinoma is usually positive 
for TTF1, HBME-1, and CK19, and partially positive for 
vimentin, CD31 and CD34 (Tuffaha 2008). The density of 
CD31 and CD34 staining is associated with microvessel 
intensity (Jiang et al. 2014). The present case had CD31- 
and CD34-positive dense microvessels in the whole 
Fig. 3 Postoperative magnetic resonance imaging. Postoperative axial (a) and sagittal (b) views of gadolinium-enhanced T1-weighted and c 
T2-weighted MRI, showing total resection of the tumor and no ischemic and contusional complications
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tumor, which was an additional reason for the difficulty 
of accurate diagnosis. TTF-1 was the most diagnostically 
positive marker in this case.
Survival is generally good in patients with differenti-
ated PTC (Chiu et al. 1997). However, distatant metasta-
ses and local tumor infiltration can be fatal, as supported 
by the high mortality associated with brain metastasis of 
PTC (McConahey et al. 1986).
There is no clearly defined protocol for management of 
intracranial metastases of thyroid cancer, but surgery is 
generally considered to be the best choice for prolonged 
survival and regression of neurological symptoms (Agu-
iar et  al. 2001; Blankenship et  al. 2005; Pazaitou-Panay-
iotou et  al. 2005; Al-Dhahri et  al. 2009; Kim et  al. 2009; 
Bernad et al. 2010). Chiu et al. (1997) reported a signifi-
cant increase in median survival (16.7 months) for those 
patients who were performed surgical resection of their 
metastases, compared with 3.4  months for those who 
did not. Moreover, the data of McWilliams et al. showed 
supported that assertion, with survivals of 18.7, 25.5, and 
2.7 months, respectively, reported for those patients who 
underwent gross total resection, partial resection, and no 
surgery (McWilliams et al. 2003). It is possible that radio-
surgery would be generally candidate-therapy for a single, 
small-sized metastasis as previously described (Muacevic 
et  al. 2008). However, since our preoperative diagnosis 
was hemangioblastoma, we selected surgical resection 
with meaning of acquiring a accurate diagnosis. In pre-
vious studies, patients undergoing stereotactic radiosur-
gery had overall median survival of 33–37.4 months, with 
gross total resection being an attractive option for local 
control of a solitary lesion or a few lesions (Biswal et al. 
1994; Salvati et al. 2001; Al-Dhahri et al. 2009). Previously 
published reports have noted an apparent benefit of radi-
oactive iodine treatment when uptake scans in the brain 
are positive (Hjiyiannakis et  al. 1996). There is an excel-
lent study that reports the survival of a 15-year old girl 
with diffuse and cerebral metastasis after she was given 
an additional age-adapted high-dose radioactive iodine 
treatment (Vrachimis et  al. 2013). However, it should 
be paid enough attention to worsening of tumor growth 
during thyroid withdrawal and to aggravating of cerebral 
edema. Datz et al. recommended prophylactic glycerol for 
acute cerebral edema, rather than corticosteroids, because 
of the possibility of decreased iodine uptake from corti-
costeroids during treatment of intracranial metastases 
from thyroid carcinoma (Datz 1986). On the other hand, 
McWilliams et  al. (2003) found no evidence to support 
use of chemotherapy in patients with brain metastasis of 
thyroid carcinoma. In the present case, additional therapy 
was not given because gross total resection was achieved, 
and there has been no recurrence radiologically and 
symptomatically in 2 years of postoperative follow up.
Conclusions
We presented a rare case of cerebellar metastasis of PTC 
in which accurate diagnosis was challenging due to pre-
operative imaging and histopathological findings that 
were similar to those for solid type cerebellar hemangio-
blastoma. Cases with metastasis of a well-differentiated 
PTC generally have a favorable prognosis. However, 
since brain metastasis of a well-differentiated papillary 
thyroid carcinoma could be a relatively poor prognostic 
factor, accurate diagnosis and suitable surgical therapy or 
radiotherapy are needed. Characteristic imaging findings 
are not apparent, and thus the clinical course and history 
of treatment for thyroid carcinoma are keys for correct 
diagnosis. A hemorrhagic tendency and a hypervascular 
mass lesion might also be characteristic features of brain 
metastasis of PTC.
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